Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) FCF Margin: 2013-2025

Historic FCF Margin for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to -34.65%.

  • Fortress Biotech's FCF Margin rose 9293.00% to -34.65% in Q3 2025 from the same period last year, while for Sep 2025 it was -106.16%, marking a year-over-year increase of 5743.00%. This contributed to the annual value of -139.04% for FY2024, which is 1276.00% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's FCF Margin is -34.65%, which was up 79.36% from -167.92% recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's FCF Margin registered a high of -34.65% during Q3 2025, and its lowest value of -347.88% during Q1 2023.
  • Moreover, its 3-year median value for FCF Margin was -155.97% (2024), whereas its average is -152.57%.
  • As far as peak fluctuations go, Fortress Biotech's FCF Margin slumped by 16,266bps in 2022, and later spiked by 21,946bps in 2023.
  • Quarterly analysis of 5 years shows Fortress Biotech's FCF Margin stood at -222.44% in 2021, then crashed by 6,978bps to -292.22% in 2022, then surged by 11,693bps to -175.29% in 2023, then surged by 8,992bps to -85.36% in 2024, then soared by 9,293bps to -34.65% in 2025.
  • Its FCF Margin stands at -34.65% for Q3 2025, versus -167.92% for Q2 2025 and -148.89% for Q1 2025.